




Instance: composition-en-5137745e381296dea05060d82180475d
InstanceOf: CompositionUvEpi
Title: "Composition for actos Package Leaflet"
Description:  "Composition for actos Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/00/150/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp5137745e381296dea05060d82180475d)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - actos"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Actos is and what it is used for </li>
<li>What you need to know before you take Actos </li>
<li>How to take Actos </li>
<li>Possible side effects </li>
<li>How to store Actos </li>
<li>Contents of the pack and other information </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What actos is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What actos is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Actos contains pioglitazone. It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) 
diabetes mellitus in adults, when metformin is not suitable or has failed to work adequately. This is the 
diabetes that usually develops in adulthood. </p>
<p>Actos helps control the level of sugar in your blood when you have type 2 diabetes by helping your 
body make better use of the insulin it produces. Your doctor will check whether Actos is working 3 to 
6 months after you start taking it. </p>
<p>Actos may be used on its own in patients who are unable to take metformin, and where treatment with 
diet and exercise has failed to control blood sugar or may be added to other therapies (such as 
metformin, sulphonylurea or insulin) which have failed to provide sufficient control of blood sugar. </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Actos 
- if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in 
section 6). 
- if you have heart failure or have had heart failure in the past.<br />
- if you have liver disease.<br />
- if you have had diabetic ketoacidosis (a complication of diabetes causing rapid weight loss, 
nausea or vomiting). 
- if you have or have ever had bladder cancer. 
- if you have blood in your urine that your doctor has not checked. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Actos (also see section 4) 
- if you retain water (fluid retention) or have heart failure problems, in particular if you are over 
75 years old. If you take anti-inflammatory medicines which can also cause fluid retention and 
swelling, you must also tell your doctor. 
- if you have a special type of diabetic eye disease called macular oedema (swelling of the back 
of the eye). 
- if you have cysts on your ovaries (polycystic ovary syndrome). There may be an increased 
possibility of becoming pregnant because you may ovulate again when you take Actos. If this 
applies to you, use appropriate contraception to avoid the possibility of an unplanned 
pregnancy. 
- if you have a problem with your liver or heart. Before you start taking Actos you will have a 
blood sample taken to check your liver function. This check may be repeated at intervals. Some 
patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who 
were treated with Actos and insulin experienced the development of heart failure. Inform your 
doctor as soon as possible if you experience signs of heart failure such as unusual shortness of 
breath or rapid increase in weight or localised swelling (oedema).  </p>
<p>If you take Actos with other medicines for diabetes, it is more likely that your blood sugar could fall 
below the normal level (hypoglycaemia).  </p>
<p>You may also experience a reduction in blood count (anaemia). </p>
<p>Broken bones 
A higher number of bone fractures was seen in patients, particularly women taking pioglitazone. Your 
doctor will take this into account when treating your diabetes. </p>
<p>Children and adolescents 
Use in children and adolescents under 18 years is not recommended. </p>
<p>Other medicines and Actos 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines, including medicines obtained without a prescription. </p>
<p>You can usually continue to take other medicines whilst you are being treated with Actos. However, 
certain medicines are especially likely to affect the amount of sugar in your blood:</p>
<ul>
<li>gemfibrozil (used to lower cholesterol) </li>
<li>rifampicin (used to treat tuberculosis and other infections) 
Tell your doctor or pharmacist if you are taking any of these. Your blood sugar will be checked, and 
your dose of Actos may need to be changed. </li>
</ul>
<p>Actos with food and drink 
You may take your tablets with or without food. You should swallow the tablets with a glass of water.  </p>
<p>Pregnancy and breast-feeding 
Tell your doctor if<br />
- you are, you think you might be or are planning to become pregnant.<br />
- you are breast-feeding or if you are planning to breast-feed your baby.<br />
Your doctor will advise you to discontinue this medicine. </p>
<p>Driving and using machines 
This medicine will not affect your ability to drive or use machines but take care if you experience 
abnormal vision. </p>
<p>Actos contains lactose monohydrate<br />
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor 
before taking Actos. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>The usual starting dose is one tablet of 15 mg or of 30 mg of pioglitazone to be taken once daily. Your 
doctor may increase the dose to a maximum of 45 mg once a day. Your doctor will tell you the dose to 
take. </p>
<p>If you have the impression that the effect of Actos is too weak, talk to your doctor.  </p>
<p>When Actos is taken in combination with other medicines used to treat diabetes (such as insulin, 
chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to 
take a smaller dose of your medicines. </p>
<p>Your doctor will ask you to have blood tests periodically during treatment with Actos. This is to check 
that your liver is working normally. </p>
<p>If you are following a special diet for diabetes, you should continue with this while you are taking 
Actos. </p>
<p>Your weight should be checked at regular intervals; if your weight increases, inform your doctor. </p>
<p>If you take more Actos than you should 
If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a 
doctor or pharmacist immediately. Your blood sugar could fall below the normal level and can be 
increased by taking sugar. It is recommended that you carry some sugar lumps, sweets, biscuits or 
sugary fruit juice. </p>
<p>If you forget to take Actos 
Take Actos daily as prescribed. However if you miss a dose, just carry on with the next dose as 
normal. Do not take a double dose to make up for a forgotten tablet. </p>
<p>If you stop taking Actos 
Actos should be used every day to work properly. If you stop using Actos, your blood sugar may go 
up. Talk to your doctor before stopping this treatment. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>In particular, patients have experienced the following serious side effects: </p>
<p>Heart failure has been experienced commonly (may affect up to 1 in 10 people) in patients taking 
Actos in combination with insulin. Symptoms are unusual shortness of breath or rapid increase in 
weight or localised swelling (oedema). If you experience any of these, especially if you are over the 
age of 65, seek medical advice straight away. </p>
<p>Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients 
taking Actos. Signs and symptoms include blood in your urine, pain when urinating or a sudden need 
to urinate. If you experience any of these, talk to your doctor as soon as possible. </p>
<p>Localised swelling (oedema) has also been experienced very commonly (may affect more than 
1 in 10 people) in patients taking Actos in combination with insulin. If you experience this side effect, 
talk to your doctor as soon as possible. </p>
<p>Broken bones have been reported commonly (may affect up to 1 in 10 people) in female patients 
taking Actos and have also been reported in male patients (frequency cannot be estimated from the 
available data) taking Actos. If you experience this side effect, talk to your doctor as soon as possible. </p>
<p>Blurred vision due to swelling (or fluid) at the back of the eye has also been reported in patients taking 
Actos (frequency cannot be estimated from the available data). If you experience this symptom for the 
first time, talk to your doctor as soon as possible. Also, if you already have blurred vision and the 
symptom gets worse, talk to your doctor as soon as possible. </p>
<p>Allergic reactions have been reported with frequency not known (cannot be estimated from the 
available data) in patients taking Actos. If you have a serious allergic reaction, including hives and 
swelling of the face, lips, tongue, or throat that may cause difficulty in breathing or swallowing stop 
taking this medicine and talk to your doctor as soon as possible. </p>
<p>The other side effects that have been experienced by some patients taking Actos are: </p>
<p>common (may affect up to 1 in 10 people) 
- respiratory infection 
- abnormal vision 
- weight gain 
- numbness </p>
<p>uncommon (may affect up to 1 in 100 people) 
- inflammation of the sinuses (sinusitis)<br />
- difficulty sleeping (insomnia) </p>
<p>not known (frequency cannot be estimated from the available data) 
- increase in liver enzymes 
- allergic reactions </p>
<p>The other side effects that have been experienced by some patients when Actos is taken with other 
antidiabetic medicines are: </p>
<p>very common (may affect more than 1 in 10 people) 
- decreased blood sugar (hypoglycaemia)  </p>
<p>common (may affect up to 1 in 10 people) 
- headache 
- dizziness<br />
- joint pain 
- impotence 
- back pain 
- shortness of breath 
- small reduction in red blood cell count 
- flatulence </p>
<p>uncommon (may affect up to 1 in 100 people) 
- sugar in urine, proteins in urine 
- increase in enzymes 
- spinning sensation (vertigo) 
- sweating 
- tiredness 
- increased appetite 
Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and the blister pack after 
 EXP . The expiry date refers to the last day of that month. </p>
<p>This medicine does not require any special storage precautions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Actos contains </p>
<p>The active substance in Actos is pioglitazone.<br />
Each Actos 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride). 
Each Actos 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride). 
Each Actos 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride). </p>
<p>The other ingredients are lactose monohydrate, hyprolose, carmellose calcium and magnesium 
stearate. See section 2  Actos contains lactose monohydrate . </p>
<p>What Actos looks like and contents of the pack </p>
<p>Actos 15 mg tablets are white to off-white, round, convex tablets marked  15  on one face and 
 ACTOS  on the other face. </p>
<p>Actos 30 mg tablets are white to off-white, round, flat tablets marked  30  on one face and 
 ACTOS  on the other face. </p>
<p>Actos 45 mg tablets are white to off-white, round, flat tablets marked  45  on one face and 
 ACTOS  on the other face. 
The tablets are supplied in blister packs of 28, 56, 98, or 112 tablets. Not all the pack sizes may be 
marketed. </p>
<p>Marketing authorisation holder 
CHEPLAPHARM Arzneimittel GmbH 
Ziegelhof 17489 Greifswald 
Germany 
Manufacturer 
Takeda Ireland Limited, Bray Business Park, Kilruddery, County Wicklow, Ireland. 
Lilly S.A, Avda. de la Industria 30, 28108 Alcobendas (Madrid), Spain 
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 23-24, 17489 Greifswald, Germany.  </p>
<p>This leaflet was last approved in August 2023. Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p> </div>"""      



Instance: composition-da-5137745e381296dea05060d82180475d
InstanceOf: CompositionUvEpi
Title: "Composition for actos Package Leaflet"
Description:  "Composition for actos Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/00/150/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp5137745e381296dea05060d82180475d)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - actos"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Se den nyeste indlægsseddel på www.indlaegsseddel.dk </p>  </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal De vide, før De begynder at tage Actos  </li>
<li>Sådan skal De tage Actos </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What actos is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What actos is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Actos indeholder pioglitazon. Det er medicin mod sukkersyge og anvendes til behandling af 
type 2-diabetes mellitus (ikke-insulinkrævende sukkersyge) hos voksne, når metformin ikke er egnet 
eller ikke har haft tilstrækkelig virkning. Type 2-diabetes mellitus er den diabetesform, der normalt 
udvikler sig i voksenalderen.  </p>
<p>Actos hjælper med at kontrollere sukkerniveauet i Deres blod, hvis De har type 2-diabetes, ved at 
hjælpe Deres krop til bedre at udnytte den insulin, kroppen producerer. Når De har taget Actos i 
3-6 måneder, vil Deres læge undersøge, om medicinen virker. </p>
<p>Actos kan anvendes alene til patienter, som ikke er i stand til at tage metformin, og hos hvem diæt og 
motion ikke har været i stand til at kontrollere blodsukkeret, eller det kan anvendes som supplement til 
andre lægemidler (såsom metformin, sulfonylurinstof eller insulin), hvis disse ikke har været i stand til 
at kontrollere blodsukkeret tilstrækkeligt.  </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Actos 
- hvis De er allergisk over for pioglitazon eller et af de øvrige indholdsstoffer i dette lægemiddel 
(angivet i punkt 6). 
- hvis De lider af hjertesvigt eller tidligere har haft hjertesvigt.<br />
- hvis De har leversygdom.<br />
- hvis De har haft diabetisk ketoacidose (en komplikation ved diabetes, der giver hurtigt vægttab, 
kvalme eller opkastning). 
- hvis De har eller nogensinde har haft blærekræft. 
- hvis De har blod i urinen, og Deres læge ikke har undersøgt årsagen. </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før De tager Actos (se også punkt 4) 
- hvis De har vand i kroppen (ødemer) eller har problemer med hjertesvigt, specielt hvis De er 
over 75 år. Hvis De tager antiinflammatoriske (betændelseshæmmende) lægemidler, som også 
kan forårsage væskeophobning og hævelse, skal De også fortælle det til lægen. 
- hvis De lider af en særlig diabetisk øjenlidelse, som hedder makulaødem (væskeansamling i det 
bagerste af øjet). 
- hvis De har cyster på æggestokkene (polycystisk ovariesyndrom). Der kan være større 
sandsynlighed for at blive gravid, fordi De kan få ægløsning igen, når De tager Actos. Hvis 
dette er relevant for Dem, skal De anvende sikker prævention, så De undgår uønsket graviditet. 
- hvis De har problemer med Deres lever eller hjerte. Før De begynder at tage Actos, vil De få 
taget en blodprøve til kontrol af leverfunktionen. Denne kontrol skal måske udføres løbende. 
Nogle patienter, som har haft type 2-diabetes i mange år og samtidig har hjertesygdom, eller 
som har haft et slagtilfælde, har udviklet hjertesvigt, når de blev behandlet med Actos og insulin 
samtidig. Kontakt lægen hurtigst muligt, hvis De oplever tegn på hjertesvigt såsom usædvanlig 
åndenød, hurtig vægtstigning eller lokale væskeansamlinger (ødemer). </p>
<p>Hvis De tager Actos sammen med anden diabetesmedicin, er der en større risiko for, at Deres 
blodsukker falder til under det normale niveau (hypoglykæmi). </p>
<p>De kan også få blodmangel (anæmi). </p>
<p>Knoglebrud 
Der er set et øget antal knoglebrud hos patienter, særligt kvinder, der tog pioglitazon. Deres læge vil 
tage dette i betragtning ved planlægning af Deres behandling. </p>
<p>Børn og unge 
Actos anbefales ikke til børn og unge under 18 år. </p>
<p>Brug af anden medicin sammen med Actos 
Fortæl det altid til lægen eller på apoteket, hvis De bruger anden medicin, for nylig har brugt anden 
medicin eller planlægger at bruge anden medicin. Dette gælder også medicin, som ikke er købt på 
recept. </p>
<p>De kan normalt blive ved med at tage anden medicin, mens De får Actos. Visse typer medicin er dog 
særlig tilbøjelige til at påvirke blodsukkeret:</p>
<ul>
<li>gemfibrozil (til at sænke kolesteroltallet) </li>
<li>rifampicin (mod tuberkulose og andre infektioner) 
Fortæl det til lægen eller på apoteket, hvis De får et af disse lægemidler. De vil få kontrolleret 
blodsukkeret for at se, om De skal have ændret dosis af Actos. </li>
</ul>
<p>Brug af Actos sammen med mad og drikke 
De kan tage Deres tabletter i forbindelse med et måltid, men det er ikke nødvendigt. De skal tage 
tabletterne med et glas vand.  </p>
<p>Graviditet og amning 
Fortæl Deres læge<br />
- hvis De er, tror De er eller planlægger at blive gravid.<br />
- hvis De ammer eller ønsker at amme Deres barn. 
Deres læge vil råde Dem til at stoppe med at tage denne medicin. </p>
<p>Trafik- og arbejdssikkerhed 
Dette lægemiddel vil ikke påvirke Deres evne til at køre bil eller arbejde med maskiner, men vær 
forsigtig, hvis De får synsforstyrrelser. </p>
<p>Actos indeholder lactosemonohydrat 
Kontakt lægen, før De tager Actos, hvis lægen har fortalt Dem, at De ikke tåler visse sukkerarter. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens anvisning. Er De i tvivl, så spørg lægen eller 
apotekspersonalet. </p>
<p>Den normale start dosis er 1 tablet på 15 mg eller 30 mg pioglitazon en gang daglig. Deres læge kan 
øge dosis til maksimalt 45 mg en gang daglig. Deres læge vil fortælle Dem hvilken dosis, De skal 
tage.  </p>
<p>Tal med lægen, hvis De har indtryk af, at effekten af Actos er for svag. </p>
<p>Når Actos tages sammen med andre lægemidler, der anvendes til behandling af sukkersyge (f.eks. 
insulin, chlorpropamid, glibenclamid, gliclazid, tolbutamid), vil Deres læge give Dem besked på, om 
De skal tage en mindre dosis af lægemidlerne. </p>
<p>Deres læge vil bede Dem om at få taget blodprøver periodevis, mens De er i behandling med Actos. 
Dette sker for at checke, at Deres lever fungerer normalt.  </p>
<p>Hvis De følger en særlig diæt på grund af Deres diabetes, skal De fortsætte med denne diæt, mens De 
tager Actos. </p>
<p>De skal tjekke Deres vægt med jævne mellemrum; hvis vægten stiger, underret da Deres læge. </p>
<p>Hvis De har taget for meget Actos 
Kontakt lægen, skadestuen eller apoteket, hvis De ved en fejltagelse har taget for mange tabletter, eller 
hvis en anden eller et barn tager Deres medicin. Blodsukkeret kan derved falde til under det normale 
niveau og kan bringes til at stige igen ved indtagelse af sukker. Det anbefales, at De altid medbringer 
sukkerknalder, slik, kiks eller sød frugtjuice. </p>
<p>Hvis De har glemt at tage Actos 
Tag Actos dagligt som foreskrevet. Hvis De glemmer en dosis, skal De imidlertid bare fortsætte med 
den næste dosis som normalt. De må ikke tage en dobbeltdosis som erstatning for glemte enkeltdoser. </p>
<p>Hvis De holder op med at tage Actos<br />
For at opnå den ønskede virkning skal De tage Actos hver dag. Hvis De holder op med at tage Actos, 
kan Deres blodsukker stige. Tal med lægen, før De stopper behandlingen. </p>
<p>Spørg lægen eller apoteketspersonalet, hvis der er noget, De er i tvivl om.  </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Patienterne har især oplevet følgende alvorlige bivirkninger: </p>
<p>Hjertesvigt har været almindeligt forekommende (kan påvirke op til 1 ud af 10 behandlede) hos 
patienter, der tager Actos i kombination med insulin. Symptomerne er usædvanlig åndenød, hurtig 
vægtstigning eller lokale væskeansamlinger (ødemer). Kontakt hurtigst muligt Deres læge, hvis De 
oplever nogle af disse bivirkninger, særligt hvis De er over 65 år. </p>
<p>Blærekræft forekommer med hyppigheden "ikke almindelig" (kan påvirke op til 
1 ud af 100 behandlede) hos patienter, der tager Actos. Tegn og symptomer omfatter blod i urinen, </p>
<p>smerter ved vandladning eller en pludselig vandladningstrang. Hvis De oplever nogen af disse 
symptomer, skal De hurtigst muligt kontakte Deres læge. </p>
<p>Lokale væskeansamlinger (ødemer) har ligeledes været meget almindeligt forekommende (kan påvirke 
flere end 1 ud af 10 behandlede) hos patienter, der tager Actos i kombination med insulin. Kontakt 
hurtigst muligt Deres læge, hvis De oplever denne bivirkning. </p>
<p>Knoglebrud har været almindeligt forekommende (kan påvirke op til 1 ud af 10 behandlede) hos 
kvindelige patienter, der tager Actos, og er ligeledes indberettet hos mandlige patienter (hyppighed 
kan ikke vurderes ud fra de tilgængelige data). Kontakt hurtigst muligt Deres læge, hvis De oplever 
denne bivirkning. </p>
<p>Synsforstyrrelser på grund af hævelse (eller væske) bagest i øjet er ligeledes blevet indberettet hos 
patienter, der tager Actos (hyppigheden kan ikke vurderes ud fra de tilgængelige data). Hvis De får 
disse symptomer for første gang, eller hvis de bliver værre, skal De kontakte lægen snarest muligt. De 
skal også kontakte Deres læge hurtigst muligt, hvis De allerede har sløret syn, og symptomerne 
forværres. </p>
<p>Der er rapporteret om allergiske reaktioner med ukendt hyppighed (kan ikke vurderes ud fra de 
tilgængelige data) hos patienter, der tager Actos. Hvis du får en alvorlig allergisk reaktion, herunder 
nældefeber og hævelse af ansigtet, læber, tunge eller svælg, der kan forårsage vejrtræknings- eller 
synkebesvær, skal du afbryde behandlingen og kontakte en læge så hurtigt som muligt. </p>
<p>Andre bivirkninger, der er forekommet hos nogle patienter, når de har taget Actos: </p>
<p>almindelige (kan påvirke op til 1 ud af 10 behandlede) 
- luftvejsinfektion 
- synsforstyrrelser 
- vægtstigning 
- følelsesløshed </p>
<p>ikke almindelige (kan påvirke op til 1 ud af 100 behandlede) 
- bihulebetændelse (sinuitis)<br />
- søvnløshed (insomni) </p>
<p>ikke kendt (hyppigheden kan ikke vurderes ud fra de tilgængelige data) 
- forhøjede leverenzymer 
- allergiske reaktioner </p>
<p>Andre bivirkninger, der er forekommet hos nogle patienter, når de har taget Actos sammen med anden 
medicin mod diabetes: </p>
<p>meget almindelige (kan påvirke mere end 1 ud af 10 behandlede) 
- lavt blodsukker (hypoglykæmi)  </p>
<p>almindelige (kan påvirke op til 1 ud af 10 behandlede) 
- hovedpine 
- svimmelhed<br />
- ledsmerter 
- impotens 
- rygsmerter 
- kortåndethed 
- let nedsat antal røde blodlegemer (blodmangel) 
- luftafgang fra tarmen </p>
<p>ikke almindelige (kan påvirke op til 1 ud af 100 behandlede) 
- sukker i urinen, protein i urinen </p>
<ul>
<li>forhøjede enzymtal </li>
<li>svimmelhed, hvor det føles som om, at verden drejer rundt (vertigo) </li>
<li>svedudbrud </li>
<li>træthed </li>
<li>øget appetit </li>
</ul>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store actos"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store actos"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på æsken og blisterkortet efter EXP. Udløbsdatoen 
er den sidste dag i den nævnte måned. </p>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. </p>
<p>Spørg apoteketspersonalet, hvordan De skal bortskaffe medicinrester. Af hensyn til miljøet må De ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Actos indeholder 
− 
Aktivt stof: pioglitazon.<br />
Hver Actos 15 mg tablet indeholder 15 mg pioglitazon (som hydrochlorid). 
Hver Actos 30 mg tablet indeholder 30 mg pioglitazon (som hydrochlorid). 
Hver Actos 45 mg tablet indeholder 45 mg pioglitazon (som hydrochlorid). 
− 
Øvrige indholdsstoffer: lactosemonohydrat, hydroxypropylcellulose, carmellosecalcium og 
magnesiumstearat. Se punkt 2 "Actos indeholder lactosemonohydrat". </p>
<p>Udseende og pakningsstørrelser 
− 
Actos 15 mg tabletter er hvide til grålighvide, runde, konvekse tabletter, der er mærkede med 
‘15’ på den ene side og ‘ACTOS’ på den anden side.<br />
− 
Actos 30 mg tabletter er hvide til grålighvide, runde, flade tabletter, der er mærkede med ‘30’ på 
den ene side og ‘ACTOS’ på den anden side.<br />
− 
Actos 45 mg tabletter er hvide til grålighvide, runde, flade tabletter, der er mærkede med ‘45’ på 
den ene side og ‘ACTOS’ på den anden side.<br />
Tabletterne leveres i blisterpakninger a 28, 56, 98 eller 112 tabletter.<br />
Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen 
CHEPLAPHARM Arzneimittel GmbH 
Ziegelhof 17489 Greifswald 
Tyskland  </p>
<p>Fremstiller 
Takeda Ireland Limited, Bray Business Park, Kilruddery, County Wicklow, Irland.<br />
Lilly S.A., Avda. de la Industria 30, 28108 Alcobendas (Madrid), Spanien. 
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Tyskland  </p>
<p>Denne indlægsseddel blev senest ændret august 2023. De kan finde yderligere oplysninger om Actos på Det Europæiske Lægemiddelagenturs hjemmeside 
http://www.ema.europa.eu. </p> </div>"""      





                    
Instance: bundlepackageleaflet-en-5137745e381296dea05060d82180475d
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for actos Package Leaflet for language en"
Description: "ePI document Bundle for actos Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-5137745e381296dea05060d82180475d"
* entry[0].resource = composition-en-5137745e381296dea05060d82180475d

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp5137745e381296dea05060d82180475d"
* entry[=].resource = mp5137745e381296dea05060d82180475d
                            
                    
Instance: bundlepackageleaflet-da-5137745e381296dea05060d82180475d
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for actos Package Leaflet for language da"
Description: "ePI document Bundle for actos Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-5137745e381296dea05060d82180475d"
* entry[0].resource = composition-da-5137745e381296dea05060d82180475d

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp5137745e381296dea05060d82180475d"
* entry[=].resource = mp5137745e381296dea05060d82180475d
                            
                    



Instance: mp5137745e381296dea05060d82180475d
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Actos 15 mg tablets"
Description: "Actos 15 mg tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/00/150/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Actos 15 mg tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 5137745e381296dea05060d82180475dListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "actos"

* status = #current
* mode = #working

* title = "List of all ePIs associated with actos"

* subject = Reference(mp5137745e381296dea05060d82180475d)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#actos "actos"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-5137745e381296dea05060d82180475d) // actos en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-5137745e381296dea05060d82180475d) // actos da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-5137745e381296dea05060d82180475d
InstanceOf: List

* insert 5137745e381296dea05060d82180475dListRuleset
    